Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T‐Cell‐Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice
Sonja Schötterl(Hertie Institute for Clinical Brain Research), Ulrike Naumann(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 10
Related Papers
APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis
|Cell Death and Differentiation|2001|88
Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma<i>In Vitro</i>and<i>In Vivo</i>in Glioblastoma Bearing Mice
|Evidence-based Complementary and Alternative Medicine|2019|15
Carboxypeptidase E transmits its anti-migratory function in glioma cells via transcriptional regulation of cell architecture and motility regulating factors
|International Journal of Oncology|2017|13